Ferriprox Warnings

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Warnings

AGRANULOCYTOSIS/NEUTROPENIA: FERRIPROX can cause agranulocytosis that can lead to serious infections and death. Neutropenia may precede the development of agranulocytosis (see Precautions).
Measure the absolute neutrophil count (ANC) before starting FERRIPROX and monitor the ANC weekly on therapy (see Precautions).
Interrupt FERRIPROX if infection develops and monitor the ANC more frequently (see Precautions).
Advise patients taking FERRIPROX to report immediately any symptoms indicative of infection (see Precautions).

deferiprone

Manufacturer:

Apotex Inc

Marketer:

Quamed